>

>

How to forecast R&D costs and allocate resources appropriately for a rare disease company?

Service Areas
Therapeutic Areas

Gene Therapy & Orphan Disease

Client Type

Mid-size Pharma

Client Problems

  • What is a starting point for R&D resource needs for a Buy Up?


  • What are the drivers by activity and/or function?


  • What is the expected R&D resource demand across the portfolio?

What We Did

  • Determined the R&D costs and cost drivers specific to the client and rare diseases


  • Created activity drivers and generic cost profiles.


  • Delivered an dynamic activity based costing tool for R&D forecasting in MS Excel.

Our Results And Insight

  • Estimate resource demand for new investments, one-off studies, and projects entering development


  • Forecast internal FTE demand by phase and Line


  • Use activity-based costing “driver” algorithms to interpolate resources based on key inputs like sites, patients, etc.


  • “Model has been used by client ever since for portfolio planning”

See other case studies

Portfolio Management case studies >

Gene Therapy & Orphan Disease case studies >

Service Areas Details

Portfolio Management (Activity-Based Costing)

Therapeutic Areas Details

Gene Therapy & Orphan Drugs (Orphan)

© 2019, First Principles Advisory Group. All Rights Reserved
SF Bay Area, Denver, Seattle, New York City, Cambridge
First Principles Advisory Group
1290 Howard Street Suite 323
Burlingame, CA 94010
(415) 669-5183
info@fpadvisory.net